Loading...

You're on the old version of Simply Wall St. We will no longer be supporting this site, so we recommend you switch to our brand new platform.

Handicare Group

BATS-CHIXE:HANDIS
Snowflake Description

Adequate balance sheet and fair value.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
HANDIS
BATS-CHIXE
SEK1B
Market Cap
  1. Home
  2. GB
  3. Healthcare
Company description

Handicare Group AB (publ) provides mobility solutions for physically challenged or elderly people in North America, Asia, and Europe. The last earnings update was 55 days ago. More info.


Add to Portfolio Compare Print
  • Handicare Group has significant price volatility in the past 3 months.
HANDIS Share Price and Events
7 Day Returns
8.2%
BATS-CHIXE:HANDIS
-1.2%
GB Medical Equipment
0.1%
GB Market
1 Year Returns
-
BATS-CHIXE:HANDIS
-0.3%
GB Medical Equipment
-23.6%
GB Market
HANDIS Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Handicare Group (HANDIS) 8.2% -34.4% -46% - - -
GB Medical Equipment -1.2% -12% -19.1% -0.3% -2.3% 20.9%
GB Market 0.1% -15.5% -27% -23.6% -24.3% -23.5%
1 Year Return vs Industry and Market
  • No trading data on HANDIS.
  • No trading data on HANDIS.
Price Volatility
HANDIS
Industry
5yr Volatility vs Market

Value

 Is Handicare Group undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Handicare Group to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Handicare Group.

BATS-CHIXE:HANDIS Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 3 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 7.7%
Perpetual Growth Rate 10-Year GB Government Bond Rate 0.5%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for BATS-CHIXE:HANDIS
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year GB Govt Bond Rate 0.5%
Equity Risk Premium S&P Global 5.4%
Medical Equipment Unlevered Beta Simply Wall St/ S&P Global 0.81
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.808 (1 + (1- 22%) (106.88%))
1.322
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
1.32
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 0.53% + (1.322 * 5.44%)
7.72%

Discounted Cash Flow Calculation for BATS-CHIXE:HANDIS using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Handicare Group is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

Note: Free cash flow to equity valuations ignore the company's cash or debt.

BATS-CHIXE:HANDIS DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (EUR, Millions) Source Present Value
Discounted (@ 7.72%)
2020 9.50 Analyst x2 8.82
2021 19.33 Analyst x3 16.66
2022 23.33 Analyst x3 18.67
2023 25.25 Est @ 8.22% 18.75
2024 26.74 Est @ 5.91% 18.44
2025 27.89 Est @ 4.3% 17.85
2026 28.78 Est @ 3.17% 17.10
2027 29.46 Est @ 2.38% 16.25
2028 30.00 Est @ 1.82% 15.36
2029 30.43 Est @ 1.43% 14.46
Present value of next 10 years cash flows €162.00
BATS-CHIXE:HANDIS DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2029 × (1 + g) ÷ (Discount Rate – g)
= €30.43 × (1 + 0.53%) ÷ (7.72% – 0.53%)
€425.26
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= €425.26 ÷ (1 + 7.72%)10
€202.10
BATS-CHIXE:HANDIS Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= €162.00 + €202.10
€364.10
Equity Value per Share
(EUR)
= Total value / Shares Outstanding
= €364.10 / 58.94
€6.18
BATS-CHIXE:HANDIS Discount to Share Price
Calculation Result
Exchange Rate EUR/SEK
(Reporting currency to currency of OM:HANDI)
10.918
Value per Share
(SEK)
= Value per Share in EUR x Exchange Rate (EUR/SEK)
= €6.18 x 10.918
SEK67.45
Non-primary Listing Adjustment Factor 1 share in BATS-CHIXE:HANDIS represents 1.01961x of OM:HANDI
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
1.01961x
Value per Share
(Listing Adjusted, SEK)
= Value per Share (SEK) x Listing Adjustment Factor
= SEK 67.45 x 1.01961
SEK68.77
Value per share (SEK) From above. SEK68.77
Current discount Discount to share price of SEK20.80
= -1 x (SEK20.80 - SEK68.77) / SEK68.77
69.8%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Handicare Group is available for.
Intrinsic value
>50%
Share price is SEK20.8 vs Future cash flow value of SEK68.77
Current Discount Checks
For Handicare Group to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Handicare Group's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • Handicare Group's share price is below the future cash flow value, and at a substantial discount (> 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Handicare Group's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Handicare Group's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
BATS-CHIXE:HANDIS PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-12-31) in EUR €-0.04
OM:HANDI Share Price ** OM (2020-04-07) in SEK SEK20.4
OM:HANDI Share Price converted to EUR reporting currency Exchange rate (SEK/ EUR) 0.092 €1.87
United Kingdom of Great Britain and Northern Ireland Medical Equipment Industry PE Ratio Median Figure of 11 Publicly-Listed Medical Equipment Companies 25.55x
United Kingdom of Great Britain and Northern Ireland Market PE Ratio Median Figure of 748 Publicly-Listed Companies 12.61x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Handicare Group.

BATS-CHIXE:HANDIS PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= OM:HANDI Share Price ÷ EPS (both in EUR)

= 1.87 ÷ -0.04

-47.88x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Handicare Group is loss making, we can't compare its value to the GB Medical Equipment industry average.
  • Handicare Group is loss making, we can't compare the value of its earnings to the United Kingdom of Great Britain and Northern Ireland market.
Price based on expected Growth
Does Handicare Group's expected growth come at a high price?
Raw Data
BATS-CHIXE:HANDIS PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -47.88x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 3 Analysts
76.3%per year
United Kingdom of Great Britain and Northern Ireland Medical Equipment Industry PEG Ratio Median Figure of 8 Publicly-Listed Medical Equipment Companies 2x
United Kingdom of Great Britain and Northern Ireland Market PEG Ratio Median Figure of 517 Publicly-Listed Companies 0.99x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Handicare Group, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Handicare Group's assets?
Raw Data
BATS-CHIXE:HANDIS PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-12-31) in EUR €2.94
OM:HANDI Share Price * OM (2020-04-07) in SEK SEK20.4
OM:HANDI Share Price converted to EUR reporting currency Exchange rate (SEK/ EUR) 0.092 €1.87
United Kingdom of Great Britain and Northern Ireland Medical Equipment Industry PB Ratio Median Figure of 20 Publicly-Listed Medical Equipment Companies 2.83x
United Kingdom of Great Britain and Northern Ireland Market PB Ratio Median Figure of 1,323 Publicly-Listed Companies 1.11x
BATS-CHIXE:HANDIS PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= OM:HANDI Share Price ÷ Book Value per Share (both in EUR)

= 1.87 ÷ 2.94

0.64x

* Primary Listing of Handicare Group.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Handicare Group is good value based on assets compared to the GB Medical Equipment industry average.
X
Value checks
We assess Handicare Group's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Medical Equipment industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Medical Equipment industry average (and greater than 0)? (1 check)
  5. Handicare Group has a total score of 3/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Handicare Group expected to perform in the next 1 to 3 years based on estimates from 3 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
76.3%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Handicare Group expected to grow at an attractive rate?
  • Handicare Group's earnings growth is expected to exceed the low risk savings rate of 0.5%.
Growth vs Market Checks
  • Handicare Group's earnings growth is expected to exceed the United Kingdom of Great Britain and Northern Ireland market average.
  • Handicare Group's revenue growth is positive but not above the United Kingdom of Great Britain and Northern Ireland market average.
Annual Growth Rates Comparison
Raw Data
BATS-CHIXE:HANDIS Future Growth Rates Data Sources
Data Point Source Value (per year)
BATS-CHIXE:HANDIS Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 3 Analysts 76.3%
BATS-CHIXE:HANDIS Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 3 Analysts 2%
United Kingdom of Great Britain and Northern Ireland Medical Equipment Industry Earnings Growth Rate Market Cap Weighted Average 21.1%
United Kingdom of Great Britain and Northern Ireland Medical Equipment Industry Revenue Growth Rate Market Cap Weighted Average 6.2%
United Kingdom of Great Britain and Northern Ireland Market Earnings Growth Rate Market Cap Weighted Average 15.5%
United Kingdom of Great Britain and Northern Ireland Market Revenue Growth Rate Market Cap Weighted Average 2.5%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
BATS-CHIXE:HANDIS Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 3 Analyst Estimates (S&P Global) See Below
All numbers in EUR Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
BATS-CHIXE:HANDIS Future Estimates Data
Date (Data in EUR Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2022-12-31 276 29 17 3
2021-12-31 271 25 15 3
2020-12-31 235 12 3 3
2020-04-07
BATS-CHIXE:HANDIS Past Financials Data
Date (Data in EUR Millions) Revenue Cash Flow Net Income *
2019-12-31 271 25 -2
2019-09-30 293 29 11
2019-06-30 292 19 11
2019-03-31 293 27 13
2018-12-31 291 23 11
2018-09-30 271 11 9
2018-06-30 275 12 0
2018-03-31 276 7 -4
2017-12-31 284 9 -5
2017-09-30 286 17 -11
2017-06-30 275 8 -11
2017-03-31 257 5 -16

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Handicare Group's earnings are expected to grow significantly at over 20% yearly.
  • Handicare Group's revenue is expected to grow by 2% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
BATS-CHIXE:HANDIS Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 3 Analyst Estimates (S&P Global) See Below

All data from Handicare Group Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

BATS-CHIXE:HANDIS Future Estimates Data
Date (Data in EUR Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2022-12-31 0.27 0.29 0.25 3.00
2021-12-31 0.25 0.29 0.22 3.00
2020-12-31 0.04 0.18 -0.12 3.00
2020-04-07
BATS-CHIXE:HANDIS Past Financials Data
Date (Data in EUR Millions) EPS *
2019-12-31 -0.04
2019-09-30 0.19
2019-06-30 0.18
2019-03-31 0.22
2018-12-31 0.19
2018-09-30 0.16
2018-06-30 0.00
2018-03-31 -0.08
2017-12-31 -0.11
2017-09-30 -0.29
2017-06-30 -0.28
2017-03-31 -0.41

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Handicare Group is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess Handicare Group's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United Kingdom of Great Britain and Northern Ireland market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United Kingdom of Great Britain and Northern Ireland market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Handicare Group has a total score of 3/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Handicare Group performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Handicare Group's growth in the last year to its industry (Medical Equipment).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Handicare Group does not make a profit even though their year on year earnings growth rate was positive over the past 5 years.
  • Unable to compare Handicare Group's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Handicare Group's 1-year growth to the GB Medical Equipment industry average as it is not currently profitable.
Earnings and Revenue History
Handicare Group's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Handicare Group Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

BATS-CHIXE:HANDIS Past Revenue, Cash Flow and Net Income Data
Date (Data in EUR Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-12-31 271.00 -2.30 71.60
2019-09-30 292.57 11.19 72.54
2019-06-30 292.17 10.59 72.04
2019-03-31 292.77 12.69 72.04
2018-12-31 290.87 11.39 72.14
2018-09-30 270.94 9.33 68.02
2018-06-30 274.94 0.03 68.42
2018-03-31 276.34 -3.87 69.62
2017-12-31 284.34 -4.77 70.42
2017-09-30 285.77 -11.27 71.13
2017-06-30 275.27 -10.67 68.83
2017-03-31 256.82 -15.62 63.93
2016-12-31 244.67 -19.67 60.43
2015-12-31 245.30 -39.28 100.38
2014-12-31 231.78 -29.36 99.65

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Handicare Group has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • Handicare Group used its assets less efficiently than the GB Medical Equipment industry average last year based on Return on Assets.
  • It is difficult to establish if Handicare Group improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Handicare Group's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Medical Equipment industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Handicare Group has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Handicare Group's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Handicare Group's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Handicare Group is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Handicare Group's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of Handicare Group's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is covered by short term assets, assets are 1.1x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Handicare Group Company Filings, last reported 3 months ago.

BATS-CHIXE:HANDIS Past Debt and Equity Data
Date (Data in EUR Millions) Total Equity Total Debt Cash & Short Term Investments
2019-12-31 173.40 95.10 33.80
2019-09-30 184.10 105.00 35.60
2019-06-30 179.90 104.70 29.10
2019-03-31 176.70 105.90 23.90
2018-12-31 171.27 103.08 23.57
2018-09-30 172.40 105.70 15.00
2018-06-30 167.90 105.10 15.70
2018-03-31 165.00 104.10 11.40
2017-12-31 164.65 100.45 12.89
2017-09-30 74.00 217.20 5.50
2017-06-30 81.80 221.90 6.20
2017-03-31 77.92 226.47 6.70
2016-12-31 77.92 226.47 6.70
2015-12-31 77.66 179.08 18.89
2014-12-31 91.99 225.57 23.69
  • Handicare Group's level of debt (54.8%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has been reduced over the past 5 years (245.2% vs 54.8% today).
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Whilst loss making Handicare Group has sufficient cash runway for more than 3 years if it maintains the current positive free cash flow level.
  • Whilst loss making Handicare Group has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by -49.1% per year.
X
Financial health checks
We assess Handicare Group's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Handicare Group has a total score of 4/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Handicare Group's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Handicare Group dividends. Estimated to be 4.37% next year.
If you bought SEK2,000 of Handicare Group shares you are expected to receive SEK0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Handicare Group's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Handicare Group's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
BATS-CHIXE:HANDIS Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 3 Analyst Estimates (S&P Global) See Below
United Kingdom of Great Britain and Northern Ireland Medical Equipment Industry Average Dividend Yield Market Cap Weighted Average of 5 Stocks 2.2%
United Kingdom of Great Britain and Northern Ireland Market Average Dividend Yield Market Cap Weighted Average of 588 Stocks 5.6%
United Kingdom of Great Britain and Northern Ireland Minimum Threshold Dividend Yield 10th Percentile 1.3%
United Kingdom of Great Britain and Northern Ireland Bottom 25% Dividend Yield 25th Percentile 2.6%
United Kingdom of Great Britain and Northern Ireland Top 25% Dividend Yield 75th Percentile 7.1%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

BATS-CHIXE:HANDIS Future Dividends Estimate Data
Date (Data in €) Dividend per Share (annual) Avg. No. Analysts
2022-12-31 0.10 3.00
2021-12-31 0.09 3.00
2020-12-31 0.05 3.00
2020-04-07
BATS-CHIXE:HANDIS Past Annualized Dividends Data
Date (Data in €) Dividend per share (annual) Avg. Yield (%)
2020-04-01 0.000 0.000
2019-05-08 0.050 1.519
2018-02-16 0.047 1.278

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Handicare Group has not reported any payouts.
  • Unable to verify if Handicare Group's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Handicare Group's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Handicare Group has not reported any payouts.
Future Payout to shareholders
  • Dividends after 3 years are expected to be well covered by earnings (3.2x coverage).
X
Income/ dividend checks
We assess Handicare Group's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.3%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Handicare Group afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Handicare Group has a total score of 1/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Handicare Group's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Staffan Ternström
COMPENSATION €429,949
AGE 54
TENURE AS CEO 1.7 years
CEO Bio

Mr. Staffan Ternström has been Chief Executive Officer and President of Handicare Group AB (publ) since August 14, 2018 and has been its Acting President of America since November 22, 2019. Mr. Ternström served as an Executive Vice President of Commercial at Mölnlycke Holding AB (publ ). He has served as Executive Vice President of Commercial at Mölnlycke Healthcare AB. Mr. Ternström served as Executive Vice President of Strategy at Mölnlycke Health Care AB since March 2014 and was responsible for corporate strategy development. Mr. Ternström has 26 years, including 24 years in the health care industry. He joined Mölnlycke Health Care in March 2014. He has many years of medical device experience, including working for Johnson & Johnson, where he served as President of Cordis/Biosense Webster, EMEA for six years and served as its Regional Vice President for Emerging Markets, based in Brussels. He has a solid background as an accomplished commercial leader in medical devices. He voted to the board of Eucomed, the medical devices industry body in Europe. He holds B.Sc. in Business Administration and Marketing from Göteborg School of Economics.

CEO Compensation
  • Insufficient data for Staffan to compare compensation growth.
  • Staffan's remuneration is higher than average for companies of similar size in United Kingdom of Great Britain and Northern Ireland.
Management Team Tenure

Average tenure and age of the Handicare Group management team in years:

3.8
Average Tenure
52
Average Age
  • The tenure for the Handicare Group management team is about average.
Management Team

Staffan Ternström

TITLE
President
COMPENSATION
€430K
AGE
54
TENURE
1.7 yrs

Pernilla Lindén

TITLE
CFO & IR
AGE
50
TENURE
0.7 yrs

Peter Slack

TITLE
Executive Vice President of Operations
AGE
45
TENURE
3.3 yrs

Rebecca Karlsson

TITLE
Communication & Sustainability Director

Mattias Hakeröd

TITLE
Executive Vice President of Human Resources & Enabling Functions
AGE
45

Helena Skarle

TITLE
Executive Vice President of Patient Handling Europe & Asia Pacific.
AGE
34
TENURE
4.3 yrs

Peter Lindquist

TITLE
Executive Vice President of Commercial Europe
AGE
58
TENURE
6.3 yrs

Francois Roblin

TITLE
Executive Vice President of Group Purchasing & Product Development
AGE
54
TENURE
6.3 yrs

Erik Østby

TITLE
Executive Vice President of Patient Handling Europe & ROW and Global Commercial Excellence
AGE
55
Board of Directors Tenure

Average tenure and age of the Handicare Group board of directors in years:

3.3
Average Tenure
51
Average Age
  • The tenure for the Handicare Group board of directors is about average.
Board of Directors

Lars Marcher

TITLE
Independent Chairman of the Board
COMPENSATION
€49K
AGE
57
TENURE
3.3 yrs

Johan Ek

TITLE
Vice Chairman
COMPENSATION
€18K
AGE
51
TENURE
3.3 yrs

Claes Åkesson

TITLE
Independent Director
COMPENSATION
€27K
AGE
60
TENURE
3 yrs

Joakim Andreasson

TITLE
Independent Director
COMPENSATION
€25K
AGE
37
TENURE
4.3 yrs

Maria Carell

TITLE
Independent Director
COMPENSATION
€22K
AGE
46
TENURE
4.3 yrs

Jonas Arlebäck

TITLE
Director
COMPENSATION
€18K
AGE
49
TENURE
1.9 yrs

Christina Lindstedt

TITLE
Director
AGE
51
TENURE
0.9 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (SEK) Value (SEK)
X
Management checks
We assess Handicare Group's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Handicare Group has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Company Info

Description

Handicare Group AB (publ) provides mobility solutions for physically challenged or elderly people in North America, Asia, and Europe. The company manufactures and sells curved and straight stair lifts, transfer products, lifting and repositioning aids, vehicle conversion adaptations, and medical equipment and consumables, as well as offers maintenance and installation services. It serves hospitals, long-term care facilities, home care, and private individuals through dealers, and government and local authorities. The company was founded in 1986 and is headquartered in Stockholm, Sweden.

Details
Name: Handicare Group AB (publ)
HANDIS
Exchange: BATS-CHIXE
Founded: 1986
SEK1,202,355,600
58,939,000
Website: http://www.handicaregroup.com
Address: Handicare Group AB (publ)
Ingmar Bergmans gata 4,
Stockholm,
114 34,
Sweden
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
OM HANDI Share Capital OMX Nordic Exchange Stockholm SE SEK 10. Oct 2017
LSE 0TCX Share Capital London Stock Exchange GB SEK 10. Oct 2017
BATS-CHIXE HANDIS Share Capital BATS 'Chi-X Europe' GB SEK 10. Oct 2017
Number of employees
Current staff
Staff numbers
1,040
Handicare Group employees.
Industry
Health Care Equipment
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2020/04/07 23:34
End of day share price update: 2020/04/07 00:00
Last estimates confirmation: 2020/04/07
Last earnings filing: 2020/02/12
Last earnings reported: 2019/12/31
Last annual earnings reported: 2019/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.